STEP-DOWN STRATEGY OF SPACING TNF-BLOCKERS INJECTIONS FOR ESTABLISHED RHEUMATOID ARTHRITIS IN REMISSION: A COST-UTILITY ANALYSIS BASED ON THE STRASS TRIAL

被引：1
|
作者：
Vanier, A. [1 ]
Tubach, F. [2 ]
Alfaiate, T. [3 ]
Mariette, X. [4 ]
Fautrel, B. [5 ]
机构：
[1] UPMC Univ Paris 6, Pitie Salpetriere Hosp, AP HP, Paris, France
[2] Univ Paris Diderot 7, UMR 1123, INSERM CIC EC 1425, Paris, France
[3] Hop Xavier Bichat, AP HP, Paris, France
[4] Univ Paris Sud 11, AP HP, Kremlin Bicetre, Germany
[5] UPMC Univ Paris 6, GRC EEMOIS 08, AP HP, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4473
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0280
引用
收藏
页码：178 / 178
页数：1
相关论文
共 13 条
  • [1] Step-Down Strategy of Spacing TNF-Blockers Injections for Established Rheumatoid Arthritis in Remission: A within Randomized Control Trial Based Cost-Utility Analysis
    Vanier, Antoine
    Tubach, Florence
    Alfaiate, Toni
    Mariette, Xavier
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)
    Fautrel, Bruno
    Thao Pham
    Alfaiate, Toni
    Gandjbakhch, Frederique
    Foltz, Violaine
    Morel, Jacques
    Dernis, Emmanuelle
    Gaudin, Philippe
    Brocq, Olivier
    Solau-Gervais, Elisabeth
    Berthelot, Jean-Marie
    Balblanc, Jean-Charles
    Mariette, Xavier
    Tubach, Florence
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) : 59 - 67
  • [3] TARGETING THE LOWEST EFFICACIOUS DOSE FOR RHEUMATOID ARTHRITIS PATIENTS IN REMISSION: CLINICAL AND STRUCTURAL IMPACT OF A STEP-DOWN STRATEGY TRIAL BASED ON PROGRESSIVE SPACING OF TNF-BLOCKER INJECTIONS (STRASS TRIAL)
    Fautrel, B.
    Gandjbakhch, F.
    Foltz, V.
    Pham, T.
    Morel, J.
    Alfaiate, T.
    Demis, E.
    Gaudin, P.
    Mariette, X.
    Tubach, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 72 - 72
  • [4] Tapering TNF-Blockers in Established Rheumatoid Arthritis Patients in DAS28 Remission: Results of a DAS28-Driven Step-Down Strategy Randomized Controlled Trial.
    Fautrel, Bruno
    Thao Pham
    Tubach, Florence
    Alfaiate, Toni
    Morel, Jacques
    Dernis, Emmanuelle
    Puechal, Xavier J.
    Gaudin, Philippe
    Mariette, Xavier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4169 - 4170
  • [5] Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial
    Vanier, Antoine
    Mariette, Xavier
    Tubach, Florence
    Fautrel, Bruno
    VALUE IN HEALTH, 2017, 20 (04) : 577 - 585
  • [6] Predictive Factors Of Relapse Or Persistent Stable Remission For Rheumatoid Arthritis (RA) Patients In Remission in a TNF Blocker-Spacing Strategy Trial (STRASS Trial)
    Thao Pham
    Morel, Jacques
    Alfaiate, Toni
    Dernis, Emmanuelle
    Gaudin, Philippe
    Brocq, Olivier
    Solau-Gervais, Elisabeth
    Berthelot, Jean-Marie
    Balblanc, Jean-Charles
    Mariette, Xavier
    Tubach, Florence
    Fautrel, Bruno
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1021 - S1021
  • [7] COST-UTILITY OF A PROGRESSIVE SPACING OF TOCILIZUMAB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SUSTAINED REMISSION: A MEDICO-ECONOMIC ANALYSIS OF THE TOLEDO TRIAL
    Kedra, J.
    Granger, B.
    El Houari, L.
    Tubach, F.
    Fautrel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 174 - 175
  • [8] IMPACT OF PROGRESSIVE SPACING OF TNF-BLOCKER INJECTIONS ON SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS PATIENTS IN DAS28 REMISSION: THE STRASS RANDOMIZED CONTROLED TRIAL
    Fautrel, B.
    Pham, T.
    Morel, J.
    Alfaiate, T.
    Dernis, E.
    Gaudin, P.
    Mariette, X.
    Tubach, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 224 - 224
  • [9] Cost-utility of a Progressive Spacing of Tocilizumab or Abatacept in Patients with Rheumatoid Arthritis in Sustained Remission: A Medicoeconomic Analysis of the Towards the Lowest Efficacious Dose Trial
    Kedra, Joanna
    Granger, Benjamin
    El Houari, Lina
    Tubach, Florence
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4285 - 4286
  • [10] Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: Randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone
    Verhoeven, AC
    Bibo, JC
    Boers, M
    Engel, GL
    van der Linden, S
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (10): : 1102 - 1109
12